Ben Tre Pharmaceutical JSC (HOSE:DBT)
Vietnam
· Delayed Price · Currency is VND 12,500
0.00 (0.00%)
At close: Aug 15, 2025
HOSE:DBT Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2019 | FY 2018 | FY 2017 | 2012 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | 2012 - 2016 |
| Net Income | 18,610 | 14,581 | 16,195 | 21,396 | 20,193 | 28,737 | Upgrade
|
| Depreciation & Amortization | 17,841 | 16,374 | 8,884 | 13,336 | 13,007 | 11,778 | Upgrade
|
| Other Amortization | 1,099 | 734.19 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -305.79 | - | - | - | - | -29,404 | Upgrade
|
| Loss (Gain) From Sale of Investments | -6,478 | -6,478 | 4,054 | - | - | - | Upgrade
|
| Other Operating Activities | -2,426 | -4,195 | -1,440 | -7,223 | -4,208 | -2,363 | Upgrade
|
| Change in Accounts Receivable | -126,519 | 37,638 | -12,200 | 11,450 | -44,032 | 14,561 | Upgrade
|
| Change in Inventory | -72,404 | -108,917 | 65,536 | -104,463 | 18,380 | 7,526 | Upgrade
|
| Change in Accounts Payable | 109,767 | 16,154 | -84,186 | -9,390 | 914.59 | 5,104 | Upgrade
|
| Change in Other Net Operating Assets | 4,094 | 7,313 | 3,518 | 776.47 | -15,069 | 15,135 | Upgrade
|
| Operating Cash Flow | -56,721 | -26,796 | 361.64 | -74,118 | -10,814 | 51,072 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | - | 56.16% | Upgrade
|
| Capital Expenditures | -8,432 | -14,072 | -7,318 | -6,822 | -10,513 | -9,016 | Upgrade
|
| Sale of Property, Plant & Equipment | 1,155 | 15,338 | 2,126 | - | 7,534 | 14,932 | Upgrade
|
| Investment in Securities | -5,096 | -19,496 | -32,965 | -28,148 | 2,557 | -31,676 | Upgrade
|
| Other Investing Activities | 4,139 | 4,036 | 2,812 | 6,570 | 8,519 | 7,175 | Upgrade
|
| Investing Cash Flow | -20,647 | -32,541 | -62,566 | -42,400 | 8,097 | -53,129 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 572,220 | Upgrade
|
| Long-Term Debt Issued | - | 888,931 | 782,262 | 697,476 | 538,385 | - | Upgrade
|
| Total Debt Issued | 886,988 | 888,931 | 782,262 | 697,476 | 538,385 | 572,220 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -564,853 | Upgrade
|
| Long-Term Debt Repaid | - | -861,447 | -719,327 | -592,327 | -537,279 | - | Upgrade
|
| Total Debt Repaid | -838,296 | -861,447 | -719,327 | -592,327 | -537,279 | -564,853 | Upgrade
|
| Net Debt Issued (Repaid) | 48,692 | 27,484 | 62,935 | 105,148 | 1,106 | 7,367 | Upgrade
|
| Issuance of Common Stock | 39,062 | 19,062 | 7,000 | 12,143 | - | 34,598 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -97.85 | - | - | Upgrade
|
| Common Dividends Paid | - | - | - | -13,529 | -18,343 | -12,276 | Upgrade
|
| Financing Cash Flow | 87,754 | 46,546 | 69,935 | 103,665 | -17,237 | 29,689 | Upgrade
|
| Foreign Exchange Rate Adjustments | 4.25 | 6.49 | 23.19 | - | - | - | Upgrade
|
| Net Cash Flow | 10,390 | -12,785 | 7,754 | -12,853 | -19,954 | 27,633 | Upgrade
|
| Free Cash Flow | -65,153 | -40,869 | -6,956 | -80,940 | -21,328 | 42,056 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | 49.08% | Upgrade
|
| Free Cash Flow Margin | -7.55% | -4.71% | -0.86% | -10.11% | -2.63% | 5.26% | Upgrade
|
| Free Cash Flow Per Share | -3173.44 | -2340.22 | -438.04 | - | - | 2613.12 | Upgrade
|
| Cash Interest Paid | 39,077 | 40,463 | 39,419 | 15,165 | 14,031 | 11,178 | Upgrade
|
| Cash Income Tax Paid | 10,288 | 10,687 | 1,915 | 3,736 | 3,117 | 8,026 | Upgrade
|
| Levered Free Cash Flow | - | -28,869 | - | -87,108 | 3,759 | -34,583 | Upgrade
|
| Unlevered Free Cash Flow | - | -3,799 | - | -77,618 | 12,015 | -27,597 | Upgrade
|
| Change in Working Capital | -85,062 | -47,813 | -27,332 | -101,627 | -39,806 | 42,326 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.